Cargando…
The anti-tumor effect of proteasome inhibitor MG132 for human adenoid cystic carcinoma: correlate with the emerging role of Nrf2/Keap1 signaling pathway
BACKGROUND: Adenoid cystic carcinoma (ACC) is one of the most common malignant salivary gland tumors. Moreover, the unique biological characteristics and complex structures of ACC contribute to its poor survival rates. Recently, proteasome inhibitors have been shown to elicit satisfactory therapeuti...
Autores principales: | Xu, Jiazhi, Wu, Haiwei, Sun, Jiatong, Gong, Zhiyuan, Lu, Xiaoya, Yang, Enli, Chen, Zhanwei, Huang, Shengyun, Nong, Xiaolin, Zhang, Dongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074179/ https://www.ncbi.nlm.nih.gov/pubmed/35524269 http://dx.doi.org/10.1186/s13005-022-00318-1 |
Ejemplares similares
-
Hypoxia-induced autophagy contributes to the invasion of salivary adenoid cystic carcinoma through the HIF-1α/BNIP3 signaling pathway
por: WU, HAIWEI, et al.
Publicado: (2015) -
Expression of RECK and MMP-2 in salivary adenoid cystic carcinoma: Correlation with tumor progression and patient prognosis
por: ZHOU, XIAOQING, et al.
Publicado: (2014) -
Prognosis of adenoid cystic carcinoma in head and neck region treated with different regimens—A single‐centre study
por: Cheng, Yutian, et al.
Publicado: (2022) -
The proteasomal inhibitor MG132 prevents muscular dystrophy in zebrafish
por: Winder, Steve J, et al.
Publicado: (2011) -
Proteasome inhibitor MG-132 induces MCPIP1 expression
por: Skalniak, Lukasz, et al.
Publicado: (2013)